![]() |
產(chǎn)地 | 進(jìn)口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS10947 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-RRAGA |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human RRAGA |
產(chǎn)品訂購信息:
英文名稱 Anti-RRAGA
中文名稱 RAS相關(guān)GTP結(jié)合蛋白A抗體品牌
別 名 RRAGB; Adenovirus E3 14.7 kDa-interacting protein 1; FIP1; Rag A; RAg B; RagA; RAGB; Ras related GTP binding protein A; Ras-related GTP binding protein B; RRAGA_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Horse, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 染色質(zhì)和核信號 信號轉(zhuǎn)導(dǎo)
蛋白分子量 predicted molecular weight: 37kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human RRAGA
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
RAS相關(guān)GTP結(jié)合蛋白A抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Involved in the RCC1/Ran-GTPase pathway. RRAGA may play a direct role in a TNF-alpha signaling pathway leading to induction of cell death. May alternatively act as a cellular target for adenovirus E3-14.7K, an inhibitor of TNF-alpha functions, thereby affecting cell death. Has guanine nucleotide-binding activity but undetectable intrinsic GTPase activity. biquitously expressed with highest levels of expression in skeletal muscle, heart, and brain.
Function : Has guanine nucleotide-binding activity but undetectable intrinsic GTPase activity. Required for the amino acid-induced relocalization of mTORC1 to the lysosomes and its subsequent activation by the GTPase RHEB. This is a crucial step in the activation of the TOR signaling cascade by amino acids. Involved in the RCC1/Ran-GTPase pathway. May play a direct role in a TNF-alpha signaling pathway leading to induction of cell death. May alternatively act as a cellular target for adenovirus E3-14.7K, an inhibitor of TNF-alpha functions, thereby affecting cell death.
Subunit : Binds GTP. Can occur as a homodimer or as a heterodimer with RRAGC or RRAGD in a sequence-independent manner; heterodimerization stabilizes PPAG proteins. In complex with RRAGC, but not with RRAGB, interacts with RPTOR. The GTP-bound form of RRAGA interacts with NOL8. Interacts with adenovirus E3 14.7 kDa protein.
Subcellular Location : Cytoplasm. Nucleus. Lysosome. Note=Predominantly cytoplasmic. May shuttle between the cytoplasm and nucleus, depending on the bound nucleotide state. Colocalizes in vivo with adenovirus E3-14.7K mainly to the cytoplasm especially near the nuclear membrane and in discrete foci on or near the plasma membrane.
Tissue Specificity : Ubiquitously expressed with highest levels of expression in skeletal muscle, heart, and brain.
Similarity : Belongs to the GTR/RAG GTP-binding protein family.
Database links : UniProtKB/Swiss-Prot: Q7L523.1
Anti-CACH2/CaV1.2/FITC 熒光素標(biāo)記L型鈣通道蛋白抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-HDAC7/FITC 熒光素標(biāo)記組蛋白去乙?;?抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh CECR5 貓眼綜合征染色體候選基因5抗體 規(guī)格 0.2ml
STAT6(signal transducers and activators of transduction 6) 信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子6抗原 0.5mg
IRS1 英文名稱: 受體底物-1抗體 0.2ml
Rhesus antibody Rh TIE1 生成素受體1抗體 規(guī)格 0.1ml
Anti-HDAC7/FITC 熒光素標(biāo)記組蛋白去乙?;?抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti--phospho-P70 S6 Kinase beta (Thr228) /FITC 熒光素標(biāo)記抗磷酸化核糖體S6蛋白激酶抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Goat Anti-human IgG 羊抗人IgG (親和層析純化)Multi-class antibodies規(guī)格: 1mg
半乳糖凝集素-3抗體 Anti-Galectin-3 0.1ml
Goat Anti-Mouse IgG/Bio 生物素標(biāo)記的羊抗小鼠IgG 0.1ml
FOXN2 英文名稱: 叉頭蛋白N2抗體 0.2ml
Rhesus antibody Rh phospho-SOX9(Ser181) 磷酸化轉(zhuǎn)錄因子SOX9蛋白抗體 規(guī)格 0.1ml
Goat Anti-human IgG 羊抗人IgG (親和層析純化)Multi-class antibodies規(guī)格: 1mg
NKB(Human Neurokinins B) ELISA Kit 人神經(jīng)激肽BMulti-class antibodies規(guī)格: 48T
Anti-HAI-1 肝細(xì)胞生長因子激活物抑制劑抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh MLCK 肌球蛋白輕鏈激酶抗體 規(guī)格 0.1ml
NE(Human neutrophil elastase) ELISA Kit 人中性粒細(xì)胞彈性蛋白酶 96T
STAT4 英文名稱: 信號轉(zhuǎn)導(dǎo)和轉(zhuǎn)錄激活因子4抗體 0.1ml
CD97 antigen subunit alpha 英文名稱: 白細(xì)胞抗原CD97 alpha 抗體 0.1ml
Anti-HAI-1 肝細(xì)胞生長因子激活物抑制劑抗體Multi-class antibodies規(guī)格: 0.2ml
梭菌鑒別瓊脂(DCA)250g用于干燥食品亞鹽還原梭菌的計(jì)數(shù)和培養(yǎng)
Honda 氏產(chǎn)毒肉湯 Honda Toxin-Producing Broth 用于大腸埃希氏菌的產(chǎn)毒培養(yǎng)
炭疽桿菌沉淀血清 1ml 炭疽桿菌檢測用配套試劑
霉菌液體培養(yǎng)基250g/瓶用于霉菌的增菌incubationmedia霉菌液體培養(yǎng)基250g/瓶用于霉菌的增菌
m-TGEBroth
AgarmediumM(Triplesugar,ironagar)
抗生素磺胺藥物靈敏性測試瓊脂 incubation media 抗生素磺胺藥物靈敏性測試瓊脂
假單胞菌瓊脂基礎(chǔ)培養(yǎng)基/CN瓊脂 250g 用于飲用天然礦泉水檢驗(yàn)中銅綠假單胞菌的測定。(GB/T 8538-2008)
堿性L-G培養(yǎng)基基礎(chǔ)用于酸性物質(zhì)處理的結(jié)核桿菌標(biāo)本
vitaminK1
RAS相關(guān)GTP結(jié)合蛋白A抗體品牌 四酸亮綠培養(yǎng)基配套試劑 規(guī)格: 2×5支/盒 用途: 含液和煌綠,2支添加于100mL(023031)中配成TTB。
四酸煌綠增菌液配套試劑 規(guī)格: 2×5支/盒 用途: 含液和煌綠,2支添加于100mL(023030)中配成TTB。
3.4% FeCl3試劑(TDA配套試劑) 規(guī)格: 10ml/支 用途: 用于色酸脫酶試驗(yàn)。
甘油 規(guī)格: 2mL/支×10 用途: 每支添加于100mL(027050)、(027051)、(027052)或(027053)中。
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. RAS相關(guān)GTP結(jié)合蛋白A抗體品牌 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個不同的分子比來篩選最適條件;
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時,或位于酶的催化位點(diǎn)時,生物素化會降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)RAS相關(guān)GTP結(jié)合蛋白A抗體品牌 抗體的效價鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識別能力??贵w的特異性高,它的識別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競爭抑制試驗(yàn)測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測定對抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。